Share Price and Basic Stock Data
Last Updated: December 19, 2025, 8:10 pm
| PEG Ratio | -5.72 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BASF India Ltd operates within the dynamic chemicals sector, focusing on organic chemicals and other related products. The company has seen a steady revenue trajectory, with sales reported at ₹13,645 Cr for the financial year ending March 2023, up from ₹13,100 Cr in the previous year. This growth reflects a compound annual growth rate (CAGR) of around 4.2% since FY 2022. For FY 2024, revenues edged up marginally to ₹13,767 Cr, indicating a resilient performance amidst market fluctuations. The latest quarter, June 2024, reported sales of ₹3,967 Cr, showcasing a sequential growth momentum, which is promising for the upcoming quarters. However, the revenue growth has not been linear, with the company facing variations across quarters, notably a decline to ₹2,898 Cr in December 2022. This volatility suggests that while the company is on a growth path, external factors such as raw material costs and demand fluctuations could impact profitability in the short term.
Profitability and Efficiency Metrics
When analyzing BASF India’s profitability, several key metrics emerge. The net profit for FY 2023 was reported at ₹403 Cr, a decline from ₹595 Cr in FY 2022, highlighting some pressure on profit margins. The operating profit margin (OPM) stood at 5% for FY 2023, down from 7% the previous year, indicating challenges in maintaining profitability amidst rising costs. Interestingly, the latest quarterly OPM for June 2024 improved to 8%, suggesting a potential recovery. The company’s return on equity (ROE) of 13.65% and return on capital employed (ROCE) of 16.85% reflect a decent efficiency level, although they have dipped from the previous fiscal year when ROE was at 17.47%. These figures suggest that while BASF India is managing to generate returns, the downward trend in profitability metrics raises concerns about operational efficiency and cost management in the increasingly competitive chemicals market.
Balance Sheet Strength and Financial Ratios
BASF India’s balance sheet presents a mixed picture with respect to financial health. As of March 2025, the company reported total assets of ₹8,330 Cr, with a comfortable current ratio of 1.55, indicating solid short-term liquidity. The interest coverage ratio at 53.17x stands out, reflecting an ability to meet interest obligations comfortably, which is crucial in a capital-intensive industry. However, the company’s borrowings of ₹157 Cr are relatively low, suggesting a conservative approach to leveraging, which could be a double-edged sword. The price-to-book value ratio of 5.25x indicates that the stock is trading at a premium relative to its net worth, which may suggest investor optimism, but could also imply that the stock is overvalued if growth does not materialize. Overall, while the balance sheet is robust, the high valuation metrics suggest that investors should tread carefully, as they could lead to volatility if earnings do not keep pace with expectations.
Shareholding Pattern and Investor Confidence
The shareholding structure of BASF India Ltd reveals a strong promoter backing, with promoters holding 73.33% of the equity, which indicates substantial control and commitment to the company’s long-term strategy. Foreign institutional investors (FIIs) have increased their stake slightly to 4.14%, while domestic institutional investors (DIIs) hold about 6.43%. The public shareholding stands at 16.09%, with the number of shareholders reported at 63,572, reflecting a diverse investor base. However, the gradual decline in public shareholding over the last few quarters might raise concerns about retail investor confidence. The consistent promoter holding suggests stability, but the fluctuating institutional interests might reflect varying confidence levels in the company’s future prospects. Investors are likely to scrutinize the company’s performance closely, especially given the pressures on profitability and the competitive landscape.
Outlook, Risks, and Final Insight
Looking ahead, BASF India faces both opportunities and challenges. The company’s strong balance sheet and high interest coverage ratio provide a solid foundation for navigating market uncertainties. However, the declining profitability metrics signal a need for strategic operational efficiencies and cost control. Additionally, the chemicals sector is subject to external shocks, including raw material price volatility and regulatory changes, which could impact margins. Investors should remain vigilant, as the stock’s current valuation appears stretched given the recent earnings performance. As BASF India works to enhance its operational efficiency and adapt to market demands, the potential for recovery in profitability could present a buying opportunity for long-term investors. However, short-term fluctuations are likely, and investors must weigh the risks against the potential rewards in this evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 99.9 Cr. | 280 | 456/255 | 232 | 392 | 0.04 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,342 Cr. | 9,261 | 14,250/8,150 | 53.1 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 35.4 Cr. | 118 | 329/109 | 17.5 | 26.9 | 0.85 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 317 Cr. | 396 | 435/163 | 17.6 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,630.08 Cr | 1,525.81 | 65.15 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,888 | 3,582 | 2,898 | 3,277 | 3,375 | 3,707 | 3,326 | 3,360 | 3,967 | 4,248 | 3,759 | 3,189 | 3,752 |
| Expenses | 3,577 | 3,394 | 2,843 | 3,143 | 3,177 | 3,473 | 3,114 | 3,114 | 3,654 | 4,047 | 3,588 | 3,126 | 3,530 |
| Operating Profit | 311 | 188 | 55 | 134 | 198 | 234 | 212 | 246 | 312 | 201 | 170 | 63 | 222 |
| OPM % | 8% | 5% | 2% | 4% | 6% | 6% | 6% | 7% | 8% | 5% | 5% | 2% | 6% |
| Other Income | 3 | 10 | 12 | 27 | 9 | 16 | 27 | 25 | 36 | 18 | 19 | 43 | 21 |
| Interest | 5 | 4 | 3 | 2 | 8 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 |
| Depreciation | 45 | 45 | 46 | 47 | 47 | 47 | 49 | 48 | 47 | 45 | 48 | 38 | 38 |
| Profit before tax | 264 | 149 | 18 | 112 | 152 | 200 | 187 | 219 | 297 | 171 | 138 | 64 | 201 |
| Tax % | 26% | 24% | 41% | 27% | 26% | 26% | 25% | 26% | 26% | 25% | 25% | 27% | 27% |
| Net Profit | 197 | 113 | 11 | 82 | 113 | 149 | 140 | 162 | 221 | 128 | 104 | 47 | 147 |
| EPS in Rs | 45.45 | 26.13 | 2.46 | 19.03 | 26.03 | 34.45 | 32.36 | 37.31 | 50.96 | 29.56 | 23.93 | 10.88 | 34.00 |
Last Updated: August 1, 2025, 11:30 pm
Below is a detailed analysis of the quarterly data for BASF India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,189.00 Cr. (Mar 2025) to 3,752.00 Cr., marking an increase of 563.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,530.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,126.00 Cr. (Mar 2025) to 3,530.00 Cr., marking an increase of 404.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 222.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2025) to 222.00 Cr., marking an increase of 159.00 Cr..
- For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 6.00%, marking an increase of 4.00%.
- For Other Income, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 22.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 137.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00%.
- For Net Profit, as of Jun 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 100.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 34.00. The value appears strong and on an upward trend. It has increased from 10.88 (Mar 2025) to 34.00, marking an increase of 23.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,430 | 4,706 | 4,749 | 5,073 | 5,583 | 6,026 | 7,595 | 9,558 | 13,100 | 13,645 | 13,767 | 15,162 | 14,604 |
| Expenses | 4,146 | 4,572 | 4,642 | 4,802 | 5,238 | 5,861 | 7,316 | 8,926 | 12,188 | 12,958 | 12,878 | 14,415 | 13,994 |
| Operating Profit | 284 | 133 | 107 | 271 | 346 | 165 | 279 | 633 | 911 | 687 | 890 | 747 | 609 |
| OPM % | 6% | 3% | 2% | 5% | 6% | 3% | 4% | 7% | 7% | 5% | 6% | 5% | 4% |
| Other Income | -3 | 39 | 173 | 27 | 182 | 139 | -4 | 419 | 37 | 53 | 76 | 116 | 110 |
| Interest | 16 | 96 | 148 | 142 | 113 | 85 | 83 | 38 | 17 | 14 | 16 | 16 | 20 |
| Depreciation | 71 | 142 | 163 | 169 | 153 | 147 | 181 | 174 | 171 | 182 | 191 | 178 | 160 |
| Profit before tax | 194 | -66 | -30 | -12 | 261 | 72 | 10 | 840 | 760 | 543 | 759 | 670 | 538 |
| Tax % | 34% | 2% | 0% | 13% | 6% | -14% | -131% | 34% | 22% | 26% | 26% | 25% | |
| Net Profit | 128 | -67 | -30 | -14 | 246 | 82 | 23 | 553 | 595 | 403 | 563 | 499 | 399 |
| EPS in Rs | 29.54 | -15.46 | -7.02 | -3.26 | 56.95 | 18.88 | 5.28 | 127.67 | 137.42 | 93.08 | 130.15 | 115.33 | 92.15 |
| Dividend Payout % | 14% | -26% | -14% | -31% | 5% | 26% | 57% | 8% | 4% | 9% | 12% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -152.34% | 55.22% | 53.33% | 1857.14% | -66.67% | -71.95% | 2304.35% | 7.59% | -32.27% | 39.70% | -11.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 207.57% | -1.89% | 1803.81% | -1923.81% | -5.28% | 2376.30% | -2296.75% | -39.86% | 71.97% | -51.07% |
BASF India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 58% |
| 3 Years: | -7% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 13% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:40 am
Balance Sheet
Last Updated: December 10, 2025, 2:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves | 1,207 | 1,119 | 1,073 | 1,059 | 1,301 | 1,370 | 1,201 | 1,743 | 2,293 | 2,658 | 3,180 | 3,614 | 3,771 |
| Borrowings | 1,067 | 1,600 | 1,349 | 1,275 | 868 | 912 | 822 | 286 | 122 | 106 | 156 | 157 | 144 |
| Other Liabilities | 1,717 | 1,406 | 1,311 | 1,498 | 1,635 | 1,524 | 2,764 | 3,072 | 3,652 | 3,758 | 3,853 | 4,517 | 3,542 |
| Total Liabilities | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
| Fixed Assets | 526 | 1,351 | 1,289 | 1,222 | 1,117 | 957 | 965 | 817 | 763 | 793 | 759 | 694 | 682 |
| CWIP | 792 | 74 | 55 | 33 | 27 | 42 | 23 | 53 | 100 | 19 | 61 | 84 | 120 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 213 | 213 |
| Other Assets | 2,716 | 2,743 | 2,433 | 2,619 | 2,702 | 2,850 | 3,842 | 4,274 | 5,247 | 5,753 | 6,413 | 7,339 | 6,485 |
| Total Assets | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 | 7,500 |
Below is a detailed analysis of the balance sheet data for BASF India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 43.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,771.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,614.00 Cr. (Mar 2025) to 3,771.00 Cr., marking an increase of 157.00 Cr..
- For Borrowings, as of Sep 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 157.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,542.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,517.00 Cr. (Mar 2025) to 3,542.00 Cr., marking a decrease of 975.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 682.00 Cr.. The value appears to be declining and may need further review. It has decreased from 694.00 Cr. (Mar 2025) to 682.00 Cr., marking a decrease of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 36.00 Cr..
- For Investments, as of Sep 2025, the value is 213.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 213.00 Cr..
- For Other Assets, as of Sep 2025, the value is 6,485.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,339.00 Cr. (Mar 2025) to 6,485.00 Cr., marking a decrease of 854.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8,330.00 Cr. (Mar 2025) to 7,500.00 Cr., marking a decrease of 830.00 Cr..
Notably, the Reserves (3,771.00 Cr.) exceed the Borrowings (144.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 283.00 | 132.00 | 106.00 | 270.00 | -522.00 | -747.00 | -543.00 | 347.00 | 789.00 | 581.00 | 734.00 | 590.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 72 | 80 | 77 | 71 | 63 | 68 | 79 | 73 | 63 | 67 | 60 |
| Inventory Days | 136 | 106 | 85 | 93 | 94 | 99 | 93 | 73 | 66 | 71 | 68 | 80 |
| Days Payable | 138 | 98 | 117 | 120 | 117 | 103 | 133 | 126 | 112 | 108 | 114 | 118 |
| Cash Conversion Cycle | 69 | 80 | 49 | 50 | 48 | 59 | 28 | 25 | 26 | 26 | 21 | 23 |
| Working Capital Days | 49 | 43 | 43 | 36 | 28 | 32 | 10 | 26 | 34 | 37 | 44 | 40 |
| ROCE % | 12% | 0% | -2% | 5% | 9% | 1% | 6% | 23% | 34% | 20% | 25% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 763,051 | 2.78 | 317.19 | 763,051 | 2025-04-22 17:25:40 | 0% |
| Tata Large & Mid Cap Fund | 263,657 | 1.25 | 109.6 | N/A | N/A | N/A |
| Quant Small Cap Fund | 243,197 | 0.34 | 101.09 | 170,585 | 2025-12-15 01:00:05 | 42.57% |
| ICICI Prudential Smallcap Fund | 23,493 | 0.12 | 9.77 | 112,260 | 2025-12-07 01:05:46 | -79.07% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Diluted EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Cash EPS (Rs.) | 156.38 | 174.30 | 135.13 | 176.81 | 167.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Dividend / Share (Rs.) | 20.00 | 15.00 | 8.00 | 6.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 3502.51 | 3180.29 | 3151.95 | 3026.04 | 2207.98 |
| PBDIT / Share (Rs.) | 190.97 | 223.07 | 167.26 | 216.08 | 150.00 |
| PBIT / Share (Rs.) | 149.91 | 178.91 | 125.20 | 176.68 | 109.83 |
| PBT / Share (Rs.) | 154.75 | 175.32 | 125.53 | 175.54 | 194.03 |
| Net Profit / Share (Rs.) | 115.32 | 130.13 | 93.07 | 137.41 | 127.65 |
| PBDIT Margin (%) | 5.45 | 7.01 | 5.30 | 7.14 | 6.79 |
| PBIT Margin (%) | 4.27 | 5.62 | 3.97 | 5.83 | 4.97 |
| PBT Margin (%) | 4.41 | 5.51 | 3.98 | 5.80 | 8.78 |
| Net Profit Margin (%) | 3.29 | 4.09 | 2.95 | 4.54 | 5.78 |
| Return on Networth / Equity (%) | 13.65 | 17.47 | 14.91 | 25.46 | 30.93 |
| Return on Capital Employeed (%) | 16.85 | 22.73 | 18.99 | 30.89 | 24.40 |
| Return On Assets (%) | 5.99 | 7.78 | 6.13 | 9.73 | 10.74 |
| Asset Turnover Ratio (%) | 1.95 | 2.00 | 2.15 | 2.33 | 1.96 |
| Current Ratio (X) | 1.55 | 1.59 | 1.47 | 1.37 | 1.27 |
| Quick Ratio (X) | 0.92 | 1.04 | 0.87 | 0.83 | 0.78 |
| Inventory Turnover Ratio (X) | 6.18 | 2.09 | 2.27 | 2.23 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 13.00 | 6.14 | 6.44 | 7.27 | 2.35 |
| Dividend Payout Ratio (CP) (%) | 9.59 | 4.58 | 4.43 | 5.65 | 1.78 |
| Earning Retention Ratio (%) | 87.00 | 93.86 | 93.56 | 92.73 | 97.65 |
| Cash Earning Retention Ratio (%) | 90.41 | 95.42 | 95.57 | 94.35 | 98.22 |
| Interest Coverage Ratio (X) | 53.17 | 62.18 | 52.05 | 53.54 | 17.28 |
| Interest Coverage Ratio (Post Tax) (X) | 30.75 | 37.27 | 28.86 | 34.33 | 5.01 |
| Enterprise Value (Cr.) | 18377.30 | 13821.16 | 9498.38 | 13225.93 | 8803.28 |
| EV / Net Operating Revenue (X) | 1.21 | 1.00 | 0.69 | 1.01 | 0.92 |
| EV / EBITDA (X) | 22.23 | 14.31 | 13.12 | 14.14 | 13.56 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| Retention Ratios (%) | 86.99 | 93.85 | 93.55 | 92.72 | 97.64 |
| Price / BV (X) | 5.25 | 4.48 | 3.65 | 5.72 | 5.03 |
| Price / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 |
After reviewing the key financial ratios for BASF India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 156.38. This value is within the healthy range. It has decreased from 174.30 (Mar 24) to 156.38, marking a decrease of 17.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Dividend / Share (Rs.), as of Mar 25, the value is 20.00. This value exceeds the healthy maximum of 3. It has increased from 15.00 (Mar 24) to 20.00, marking an increase of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,502.51. It has increased from 3,180.29 (Mar 24) to 3,502.51, marking an increase of 322.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 190.97. This value is within the healthy range. It has decreased from 223.07 (Mar 24) to 190.97, marking a decrease of 32.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 149.91. This value is within the healthy range. It has decreased from 178.91 (Mar 24) to 149.91, marking a decrease of 29.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 154.75. This value is within the healthy range. It has decreased from 175.32 (Mar 24) to 154.75, marking a decrease of 20.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 115.32. This value is within the healthy range. It has decreased from 130.13 (Mar 24) to 115.32, marking a decrease of 14.81.
- For PBDIT Margin (%), as of Mar 25, the value is 5.45. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 5.45, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 5.62 (Mar 24) to 4.27, marking a decrease of 1.35.
- For PBT Margin (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 4.41, marking a decrease of 1.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 5. It has decreased from 4.09 (Mar 24) to 3.29, marking a decrease of 0.80.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.65. This value is below the healthy minimum of 15. It has decreased from 17.47 (Mar 24) to 13.65, marking a decrease of 3.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.85. This value is within the healthy range. It has decreased from 22.73 (Mar 24) to 16.85, marking a decrease of 5.88.
- For Return On Assets (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has decreased from 7.78 (Mar 24) to 5.99, marking a decrease of 1.79.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.95. It has decreased from 2.00 (Mar 24) to 1.95, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.55, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.92, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 6.18, marking an increase of 4.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has increased from 6.14 (Mar 24) to 13.00, marking an increase of 6.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 20. It has increased from 4.58 (Mar 24) to 9.59, marking an increase of 5.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has decreased from 93.86 (Mar 24) to 87.00, marking a decrease of 6.86.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.41. This value exceeds the healthy maximum of 70. It has decreased from 95.42 (Mar 24) to 90.41, marking a decrease of 5.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.17. This value is within the healthy range. It has decreased from 62.18 (Mar 24) to 53.17, marking a decrease of 9.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 30.75. This value is within the healthy range. It has decreased from 37.27 (Mar 24) to 30.75, marking a decrease of 6.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,377.30. It has increased from 13,821.16 (Mar 24) to 18,377.30, marking an increase of 4,556.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.21, marking an increase of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 22.23. This value exceeds the healthy maximum of 15. It has increased from 14.31 (Mar 24) to 22.23, marking an increase of 7.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For Retention Ratios (%), as of Mar 25, the value is 86.99. This value exceeds the healthy maximum of 70. It has decreased from 93.85 (Mar 24) to 86.99, marking a decrease of 6.86.
- For Price / BV (X), as of Mar 25, the value is 5.25. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 5.25, marking an increase of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BASF India Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.85% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.65% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 30.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 43.9 (Industry average Stock P/E: 65.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Unit Nos. 10A, 10B, 10C (Part), 10th Floor, Godrej One, Pirojshanagar, Mumbai Maharashtra 400079 | investor-grievance-india@basf.com http://www.basf.com/in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradip P Shah | Chairman |
| Mr. Alexander Gerding | Managing Director |
| Mr. Anil Choudhary | Whole Time Director |
| Dr. Ramkumar Dhruva | Director |
| Mrs. Shyamala Gopinath | Director |
| Mr. Marcelo Rocha Lu | Director |
| Mr. Bahram Vakil | Director |
| Ms. Sonia Singh | Director |
| Mr. Narendranath J Baliga | Whole Time Director |
| Mr. Manohar Kamath | Director - Legal |
FAQ
What is the intrinsic value of BASF India Ltd?
BASF India Ltd's intrinsic value (as of 19 December 2025) is 4260.50 which is 9.30% higher the current market price of 3,898.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 16,893 Cr. market cap, FY2025-2026 high/low of 5,950/3,786, reserves of ₹3,771 Cr, and liabilities of 7,500 Cr.
What is the Market Cap of BASF India Ltd?
The Market Cap of BASF India Ltd is 16,893 Cr..
What is the current Stock Price of BASF India Ltd as on 19 December 2025?
The current stock price of BASF India Ltd as on 19 December 2025 is 3,898.
What is the High / Low of BASF India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BASF India Ltd stocks is 5,950/3,786.
What is the Stock P/E of BASF India Ltd?
The Stock P/E of BASF India Ltd is 43.9.
What is the Book Value of BASF India Ltd?
The Book Value of BASF India Ltd is 881.
What is the Dividend Yield of BASF India Ltd?
The Dividend Yield of BASF India Ltd is 0.51 %.
What is the ROCE of BASF India Ltd?
The ROCE of BASF India Ltd is 18.0 %.
What is the ROE of BASF India Ltd?
The ROE of BASF India Ltd is 13.7 %.
What is the Face Value of BASF India Ltd?
The Face Value of BASF India Ltd is 10.0.